Key Financial Data Of Reporting Company

Fuji Pharma Co.,Ltd. - Filing #7610243

Concept 2022-01-01 to
2022-03-31
As at
2022-03-31
2021-10-01 to
2022-03-31
As at
2021-09-30
2020-10-01 to
2021-09-30
2021-01-01 to
2021-03-31
As at
2021-03-31
2020-10-01 to
2021-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
17,726,000,000 JPY
33,990,000,000 JPY
17,277,000,000 JPY
Ordinary profit (loss)
2,866,000,000 JPY
3,250,000,000 JPY
2,738,000,000 JPY
Net assets
35,750,000,000 JPY
32,681,000,000 JPY
32,564,000,000 JPY
Total assets
74,298,000,000 JPY
64,239,000,000 JPY
62,563,000,000 JPY
Basic earnings (loss) per share
29.45
75.50
90.54
25.01
68.63
Diluted earnings per share
Equity-to-asset ratio
0.481 xbrli:pure
0.509 xbrli:pure
0.520 xbrli:pure
Net cash provided by (used in) operating activities
-1,076,000,000 JPY
5,993,000,000 JPY
4,405,000,000 JPY
Net cash provided by (used in) investing activities
-10,296,000,000 JPY
-2,345,000,000 JPY
-2,018,000,000 JPY
Net cash provided by (used in) financing activities
6,988,000,000 JPY
-5,435,000,000 JPY
-3,653,000,000 JPY
Cash and cash equivalents
5,975,000,000 JPY
10,199,000,000 JPY
10,835,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.